Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20883)

• Formulation Name: Temozolomide 250 mg capsule
• Company: IDT Australia

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Temozolomide	(DMKECZD)	Adenocarcinoma	2D40	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Ferrosoferric oxide	(E00231)	14789	Colorant
methylparaben	(E00149)	7456	Antimicrobial preservative
Propyl 4-hydroxybenzoate	(E00141)	7175	Antimicrobial preservative
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant
Tartaric acid	(E00029)	875	Acidulant; Complexing agent; Flavoring agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Water	(E00035)	962	Solvent